Litcius/Paper detail

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Simon Dujardin, Caitlin Commins, Aurélien Lathuilière, Pieter Beerepoot, Analiese R. Fernandes, Tarun Kamath, Mark B. De Los Santos, Naomi Klickstein, Diana L. Corjuc, Bianca T. Corjuc, Patrick M. Dooley, Arthur Viodé, Derek H. Oakley, Ben D. Moore, Kristina Mullin, Dinorah Jean-Gilles, Ryan Clark, Kevin Atchison, Renée Moore, Lori B. Chibnik, Rudolph E. Tanzi, Matthew P. Frosch, Alberto Serrano‐Pozo, Fiona Elwood, Judith A. Steen, Matthew Kennedy, Bradley T. Hyman

2020Nature Medicine445 citationsDOIOpen Access PDF

Topics & Concepts

Diversity (politics)DiseaseAlzheimer's diseaseNeuroscienceMedicineBiologyGerontologyComputational biologyInternal medicineSociologyAnthropologyAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease | Litcius